The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hicks Derek since 2024.
This trader's CIK number is 1901282.
At the time of last reporting, Hicks Derek was the EVP, Chief Business Officer of Intellia Therapeutics, Inc.. (stock ticker symbol NTLA).
Also see all insider trading activities at Intellia Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NTLA | 0 | $0 | 6,502 | $79,194 | 0 | $0 |
| 2024 | NTLA | 0 | $0 | 3,877 | $114,216 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-03 | NTLA | Sale | 6,502 | 12.18 | 79,194 |
| 2024-01-03 | NTLA | Sale | 3,877 | 29.46 | 114,216 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hicks Derek (EVP, Chief Business Officer of Intellia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.